Michael W Drazer (Michael Drazer)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Chronic Kidney Disease

Embryonic Stem Cells

Ejection Fraction

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Genetics in medicine : official journal of the American College of Medical Genetics

This page only lists publications with an associated author ORCID identifier.

Publications

Henry W Raeder, Michael W Drazer
FLT3 agonists and secondary hematopoietic malignancies: a potential class effect. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Henry W Raeder, Michael W Drazer
FLT3 Agonists and Secondary Hematopoietic Malignancies: A Potential Class Effect. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Hannah Johnston, Hamed Rahmani Youshanlouei, Clinton Osei, Anand Ashwin Patel, Adam S DuVall, Peng Wang, Pankhuri Wanjari, Jeremy P Segal, Girish Venkataraman, Jason Xiaojun Cheng, Sandeep K Gurbuxani, Angela M Lager, Carrie Fitzpatrick, Michael J Thirman, Mariam T Nawas, Hongtao Liu, Michael W Drazer, Olatoyosi Odenike, Richard A Larson, Wendy Stock, Caner Saygin
Socioeconomic determinants of the biology and outcomes of acute lymphoblastic leukemia in adults. Blood advances (2023)
Claire C Homan, Michael W Drazer, Kai Yu, David Michael Lawrence, Jinghua Feng, Luis Alberto Arriola-Martinez, Matthew J Pozsgai, Kelsey E McNeely, Thuong Thi Ha, Parvathy Venugopal, Peer Arts, Sarah King-Smith, Jesse Jc Cheah, Mark Armstrong, Paul Wang, Csaba Bödör, Alan B Cantor, Mario Cazzola, Erin S Degelman, Courtney D D DiNardo, Nicolas Duployez, Rémi Favier, Stefan Fröhling, Ana Rio-Machin, Jeffery M Klco, Alwin Krämer, Mineo Kurokawa, Joanne Lee, Luca Malcovati, Neil V Morgan, Natsoulis Georges, Carolyn Owen, Keyur Pravinchandra Patel, Claude Preudhomme, Hana Raslova, Hugh Young Rienhoff, Tim Ripperger, Rachael R Schulte, Kiran Tawana, Elvira Velloso, Yan Benedict, Erika Mijin Kwon Kim, Raman Sood, Amy P Hsu, Steven M Holland, Kerry Phillips, Nicola Poplawski, Milena Babic, Andrew H Wei, Cecily Jane Forsyth, Helen Mar Fan, Ian Lewis, Julian P Cooney, Rachel Susman, Lucy C Fox, Piers Blombery, Deepak Singhal, Devendra K Hiwase, Belinda Phipson, Andreas W Schreiber, Christopher N Hahn, Hamish S Scott, Paul P Liu, Lucy A Godley, Anna L Brown
Somatic mutational landscape of hereditary hematopoietic malignancies caused by germ line RUNX1, GATA2, and DDX41 variants. Blood advances (2023)
Gregory W Roloff, Reid Shaw, Timothy E O'Connor, Feighanne Hathaway, Michael W Drazer
Stagnation in quality of next-generation sequencing assays for the diagnosis of hereditary hematopoietic malignancies. Journal of genetic counseling (2023)
Ellin Berman, Neil P Shah, Michael W Deininger, Jessica K Altman, Maria Amaya, Kebede H Begna, Ravi Bhatia, Onyee Chan, Robert H Collins, Peter Curtin, Daniel J DeAngelo, Michael W Drazer, Lori Maness, Leland L Metheny, Sanjay Mohan, Joseph Moore, Vivian Oehler, Keith W Pratz, Iskra Pusic, Michal Rose, William Shomali, B Douglas Smith, Michael Styler, Kendra Sweet, Moshe Talpaz, Tiffany Tanaka, Srinivas Tantravahi, Steven Tsai, Jennifer Vaughn, Jeanna Welborn, David Yang, Michael Mauro, Jorge E Cortes, Jerald Radich, Brian J Druker
CML and the WHO: Why? Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Michael W Drazer, Claire C Homan, Kai Yu, Marcela Cavalcante de Andrade Silva, Kelsey E McNeely, Matthew J Pozsgai, Maria G Acevedo-Mendez, Jeremy P Segal, Peng Wang, Jinghua Feng, Sarah L King-Smith, Erika Kim, Sophia Claire Korotev, David Michael Lawrence, Andreas W Schreiber, Christopher N Hahn, Hamish S Scott, Raman Sood, null null, Elvira Deolinda Rodrigues Pereira Velloso, Anna L Brown, Paul P Liu, Lucy A Godley
Clonal hematopoiesis in patients with ANKRD26 or ETV6 germline mutations. Blood advances 6 (15) (2022)
Simone K Feurstein, Amy M Trottier, Noel Estrada-Merly, Matthew J Pozsgai, Kelsey E McNeely, Michael W Drazer, Brian Ruhle, Katharine Sadera, Ashwin L Koppayi, Bart L Scott, Betul Oran, Taiga Nishihori, Vaibhav Agrawal, Ayman Saad, R Coleman Lindsley, Ryotaro Nakamura, Soyoung Kim, Zhen-Huan Hu, Ronald M Sobecks, Stephen R Spellman, Wael Saber, Lucy A Godley
Germline predisposition variants occur in myelodysplastic syndrome patients of all ages. Blood (2022)
Anand Ashwin Patel, Alexandra E Rojek, Michael W Drazer, Howard Weiner, Lucy A Godley, Michelle M Le Beau, Richard A Larson
Therapy-related myeloid neoplasms in 109 patients after radiation monotherapy. Blood advances 5 (20) (2021)
Gregory W Roloff, Lucy A Godley, Michael W Drazer
Assessment of technical heterogeneity among diagnostic tests to detect germline risk variants for hematopoietic malignancies. Genetics in medicine : official journal of the American College of Medical Genetics 23 (1) (2020)
Michael W Drazer, Sabah Kadri, Madina Sukhanova, Sushant A Patil, Allison H West, Simone Feurstein, Dalein A Calderon, Matthew F Jones, Caroline M Weipert, Christopher K Daugherty, Adrián A Ceballos-López, Gordana Raca, Mark W Lingen, Zejuan Li, Jeremy P Segal, Jane E Churpek, Lucy A Godley
Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood advances 2 (2) (2019)